Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastrointest Pathophysiol. Dec 31, 2019; 10(5): 54-63
Published online Dec 31, 2019. doi: 10.4291/wjgp.v10.i5.54
Table 1 Patient characteristics, n (%)
CharacteristicsUC (n = 57)CD (n = 131)
GenderFemale27 (47)83 (63)
Male30 (53)48 (37)
Disease duration (yr)0-537 (65)72 (55)
6 to 109 (16)16 (12)
> 1011 (19)43 (33)
SmokingCurrent1 (2)32 (25)
Former29 (51)37 (28)
Never27 (47)62 (47)
BiomarkersLactoferrin μg/g448 (0; 8467)95 (0; 9351)
Median (min; max)CRP mg/dL0.54 (0.4; 17.3)1.15 (0.4; 21.1)
WBC (K/μL)8.2 (4.0; 29.9)7.5 (3.6; 26.4)
Montreal age (yr)A1 < 160 (0)4 (3)
A2 17-4029 (51)47 (36)
A3 > 4028 (49)80 (61)
Montreal class UCE1 proctitis4 (7)
E2 distal17 (30)
E3 extensive36 (63)
Disease activity by DAIMild (1)11 (19)
Moderate (2)27 (48)
Severe (3)19 (33)
Montreal class CDL1 ileal45 (34)
L2 colonic57 (44)
L3 ileocolonic29 (22)
L4 isolated upper0 (0)
B1 nonstricturing95 (73)
B2 stricturing24 (18)
B3 penetrating12 (9)
P perianal4 (3)
Disease activity by SES-CDInactive (0-2)9 (10)
Mild (3-6)20 (22)
Moderate (7-15)26 (28)
Severe (≥ 16)37 (40)